"Test Discrepancies Signal Increased Risks of Kidney Failure and Heart Issues"

A study reveals that discrepancies between Creatinine and Cystatin C tests may heighten risks for kidney failure and cardiovascular disease, emphasizing the need for improved assessment of kidney function.

• Researchers found that conflicting results from Creatinine and Cystatin C tests can signal a greater risk of kidney failure and related health complications.
• The study highlights that relying solely on Creatinine may underestimate the severity of chronic kidney disease in patients, potentially leading to missed diagnoses.
• Finding a reliable biomarker for kidney function is crucial, as the study suggests that using both Cystatin C and Creatinine provides better insights into cardiovascular disease risks.